Xiaoyong Zhang

13PUBLICATIONS
37CO-AUTHORS
Haematological tumoursInnate immunityMedical molecular engineering of nucleic acids and proteinsMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 23, 2025
Relationship between HBsAg/HBV DNA and prognosis in patients with HBV-related hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors.

Qiuying Qin, Yuanyuan Zheng, Yiran Wang

|Oct 09, 2024
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.

Dan-Ling Dai, Chu Xie, Lan-Yi Zhong

|Jun 27, 2024
Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.

Sheng Shen, Ran Yan, Zhanglian Xie

|Apr 20, 2024
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.

Wei Zhu, Zhiming Zhang, Jinzhang Chen

|Feb 23, 2024
Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus.

Haixing Zhang, Xiaoran Li, Ziying Liu

|May 15, 2023
Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD-NF-κB-NR2F1 nexus.

Zhanglian Xie, Sheng Shen, Kuiyuan Huang

Pageof 3

Frequent Collaborators

3 joint publications

Hongyan Liu

3 joint publications

Haitao Guo

3 joint publications

Jinlin Hou

2 joint publications

Hu Zhang